Biotech · Private company
SOTIO Biotech a.s.
Track this companyFree. Adds SOTIO Biotech a.s. to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- SOT102Phase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- SOT109Phase 2 · Colorectal Cancer (Locally Advanced or Metastatic)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal CancerPHASE1_PHASE2 · RECRUITING · started Aug 12, 2026ClinicalTrials.gov NCT07693751 · fetched Nov 12, 2026
- BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid TumorsPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Oct 26, 2022ClinicalTrials.gov NCT05120271 · fetched Nov 12, 2026
- Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic AdenocarcinomaPHASE1_PHASE2 · TERMINATED · started Mar 31, 2022ClinicalTrials.gov NCT05525286 · fetched Nov 12, 2026
- Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsPHASE1 · TERMINATED · started Jun 13, 2019ClinicalTrials.gov NCT04234113 · fetched Nov 12, 2026